4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001328
Director sold 4,050 shares at an average $64.75 ($262,233)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OLUKOTUN ADEOYE Y Director | 2022-01-03 | Sale | −1,890 | $64.26 | $121,451 | 7,110 | D |
| OLUKOTUN ADEOYE Y Director | 2022-01-03 | Sale | −1,916 | $65.04 | $124,617 | 5,194 | D |
| OLUKOTUN ADEOYE Y Director | 2022-01-03 | Sale | −244 | $66.25 | $16,165 | 4,950 | D |
| Open-market sales · 4,050 sh · avg $64.75 · $262,233 | |||||||
Loading xslF345X03/doc4.xml…